- Report of Foreign Issuer (6-K)
01 4월 2011 - 2:39AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of March 2011
Commission File Number: 001-33340
TONGJITANG CHINESE MEDICINES COMPANY
(Translation of Registrant's name into English)
5th Floor, Block B
Nanshan Medical Device Park
1019 Nanhai Avenue, Shekou, Nanshan District
Shenzhen, 518067 Guangdong Province
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under the cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g-3-2(b) under the Securities Exchange Act of 1934.
Yes
o
No
x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82-______________.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 31, 2011
|
|
|
|
TONGJITANG CHINESE MEDICINES COMPANY
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Justin Chen
|
|
|
|
Justin Chen
|
|
|
|
Chief Operating Officer
|
|
|
|
|
|
EXHIBIT INDEX
|
|
|
99.1
|
|
Press release, dated March 31, 2011, entitled “Tongjitang Chinese Medicines Company Shareholders Vote to Approve Merger”
|
Tycom Ltd (NYSE:TCM)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Tycom Ltd (NYSE:TCM)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024